Stock 9926 AKESO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications Akeso, Inc.

Equities

9926

KYG0146B1032

Delayed Hong Kong S.E.
Other stock markets
 03:23:07 2024-04-26 am EDT 		5-day change 1st Jan Change
48.65 HKD +0.41% Intraday chart for Akeso, Inc. +10.82% +4.85%
Apr. 24 Akeso’s Supplemental New Drug Application for Cervical Cancer Drug Accepted by Chinese Regulator MT
Apr. 24 National Medical Products Administration Accepted the Supplemental New Drug Application by Akeso, Inc. for (Cadonilimab, Pd-1/Ctla-4) as First-Line Treatment for Cervical Cancer CI

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. 9926 Stock
  4. News Akeso, Inc.
  5. Official Publications